Global Fund
11
0
0
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
9.1%
1 terminated/withdrawn out of 11 trials
90.9%
+4.4% vs industry average
9%
1 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the Congo
Role: collaborator
Efficacy of Two Dual Active Ingredient Long Lasting Insecticidal Nets for Control of Malaria Transmitted by Pyrethroid Resistant Vectors in Benin
Role: collaborator
Study to Assess Efficacy of Artemether-lumefantrine Prophylaxis Against Forest Malaria in Cambodia (PAL_Cambodia)
Role: collaborator
Monitoring Of Viral Load In Decentralised Area in Vietnam
Role: collaborator
Nutritional Rehabilitation in Senegalese HIV-infected Children and Adolescents
Role: collaborator
Combination Antimalarials in Uncomplicated Malaria
Role: collaborator
A Controlled Smoking Cessation Trial and Prospective Cohort Study of Tuberculosis (TB) Treatment Outcomes
Role: collaborator
Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand
Role: collaborator
Pharmacokinetics, Efficacy, Gametocyte Carriage, Birth Outcomes Following Sulfadoxine-pyrimethamine Intermittent Presumptive Treatment in Pregnant Women
Role: collaborator
Artesunate Plus Sulfadoxine-pyrimethamine Pharmacokinetics, Efficacy, Gametocytes Carriage and Birth Outcomes in Pregnant Women With Malaria
Role: collaborator
A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria
Role: collaborator
All 11 trials loaded